FibroGen (FGEN)

• Market cap: $40.2M
• 1 day: -9.64%
• 5 days: -9.64%
• 1 month: -9.39%
• 3 months: 18.76%
• 6 months: 30.1%
• Year to date: -24.87%
• 1 year: 17.36%
• 5 years: -99.04%
• 10 years: -98.43%
• Sector: Healthcare
• Industry: Biotechnology

About: FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

Employees: 225